Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026)
Envista Holdings' (NVST) quarterly Other Non-Current Assets came in at $223.8 million in Q2 2026, down 8.54% year-on-year from $244.7 million in Q2 2025, and down 1.89% quarter-over-quarter from $228.1 million in Q4 2025.
Envista Holdings (NVST) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Envista Holdings' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $223.8 million for Q2 2026.
- On a quarterly basis, Other Non-Current Assets fell 8.54% year-over-year to $223.8 million in Q2 2026; TTM through Apr 2026 was $223.8 million, a 8.54% decrease from a year earlier, with the FY2025 full-year figure at $228.1 million, down 1.08% from the prior year.
- Other Non-Current Assets retreated to $223.8 million in Q2 2026 per NVST's latest filing, from $228.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $264.9 million in Q2 2025 and bottomed at $4.1 million in Q3 2022.
- The 5-year median for Other Non-Current Assets is $180.5 million (2023), against an average of $190.3 million.
- Across the five-year window, Other Non-Current Assets sank 97.21% in 2022 and surged 3600.0% in 2023, its largest moves.
- Year by year, Other Non-Current Assets stood at $153.7 million in 2022, then climbed by 17.44% to $180.5 million in 2023, then climbed by 27.76% to $230.6 million in 2024, then slipped by 1.08% to $228.1 million in 2025, then retreated by 1.89% to $223.8 million in 2026.
- Per Business Quant, the three latest NVST Other Non-Current Assets figures stand at $223.8 million (Q2 2026), $228.1 million (Q4 2025), and $249.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | 223.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 223.80 Mn |
| Dec 31, 2025 | 228.10 Mn |
| Sep 26, 2025 | 249.30 Mn |
| Jun 27, 2025 | 264.90 Mn |
| Mar 28, 2025 | 244.70 Mn |
| Dec 31, 2024 | 230.60 Mn |
| Sep 27, 2024 | 250.60 Mn |
| Jun 28, 2024 | 218.60 Mn |
| Mar 29, 2024 | 174.40 Mn |
| Dec 31, 2023 | 180.50 Mn |
| Sep 29, 2023 | 152.90 Mn |
| Jun 30, 2023 | 151.70 Mn |
| Mar 31, 2023 | 158.30 Mn |
| Dec 31, 2022 | 153.70 Mn |
| Sep 30, 2022 | 173.20 Mn |
| Jul 1, 2022 | 4.10 Mn |
| Apr 1, 2022 | 174.90 Mn |
| Dec 31, 2021 | 167.80 Mn |
| Jul 2, 2021 | 147.00 Mn |
| Apr 2, 2021 | 127.00 Mn |